Multibagger penny stock under 10 hit upper circuit and 52-week high on August 30
The stock gave multibagger returns of 168.5 per cent from its 52-week low of Rs 3.46 per share.
On Friday, shares of Ajooni Biotech Ltd hit a 5 per cent upper circuit to Rs 9.29 per share from its previous closing of Rs 8.85. The company has a market cap of over Rs 160 crore. The stock also made a fresh 52-week high of Rs 9.29 and its 52-week low is Rs 3.46. The stock gave multibagger returns of 168.5 per cent from its 52-week low of Rs 3.46 per share. In the recent trading sessions, the stock has been hitting back-to-back upper circuits and 52-week highs.
Ajooni Biotech Limited, a leading innovator in pure vegetarian animal healthcare solutions, prioritises quality, safety, and production advancements to deliver exceptional service and a comprehensive feed range for both pure vegetarian animal feed and supplements. By partnering with Ajooni, you gain an experienced and knowledgeable ally with a deep understanding of the livestock market. Their focus is on optimising productivity, meeting animals' complete nutritional needs through a purely vegetarian diet and achieving optimal dietary balance.
Ajooni Biotech Limited has achieved a significant milestone by entering the Gujarat B2C market with its high-quality cattle feed. This expansion demonstrates the company's commitment to innovation, quality, and customer satisfaction. As a pioneer in the pure vegetarian animal feed industry, Ajooni Biotech offers a comprehensive range of products, including feed and supplements, to meet the diverse needs of farmers and livestock owners. By establishing a direct presence in Gujarat, the company aims to strengthen its market position and provide enhanced services to its customers.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
The company secured a prestigious order valued at Rs 4.95 crore from a top 10 Indian dairy supplier, reflecting growing confidence in their products. They are expecting a total turnover of Rs 100-140 crore in FY 2024-25 and are actively expanding exports while venturing into Moringa production for biofuel in FY 2025-26, aiming for a significant rise in turnover to Rs 350-410 crore by then and Rs 450-495 crore by FY 2026-27.
Investors should keep an eye on this micro-cap stock.
Disclaimer: The article is for informational purposes only and not investment advice.
Also Read: 5:1 stock split: Penny stock under Rs 5 locked in upper circuit as company’s mining subsidiary secures total export orders worth Rs 661 crore